Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-10-14

Clinical Trial Update: Efficacy of Fecal Microbiota Transplantation for Inflammatory Bowel Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating the efficacy of fecal microbiota transplantation for inflammatory bowel disease. The study includes ulcerative colitis and Crohn's…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Saglik Bilimleri Universitesi Gulhane Tip Fakultesi | Conditions: Ulcerative Colitis, Crohn Disease | Phase 3 | Status: UNKNOWN